CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer.

We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.

Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

Shares of Moderna are trading higher Wednesday after Oracle Chairman Larry Ellison discussed the potential of artificial intelligence (AI) to revolutionize healthcare.

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...

Oracle Chairman Larry Ellison asserted that AI could be used to assist in the development of mRNA-based cancer vaccines. His statement resulted in a 7% rally by MRNA stock on Jan. 22. The shares ...